DIS3 gene mutations (DIS3mts) occur in roughly 10% of multiple myeloma (MM) patients; furthermore, DIS3 expression could be affected by monosomy 13 or del(13q), which occur in approximately 40% of MM cases. Despite several reports on the prevalence of DIS3mts, their contribution to the pathobiology of MM remains largely unknown. We took advantage of the large public CoMMpass dataset to investigate the spectrum of DIS3mts in MM and its impact on the transcriptome and clinical outcome. We found that DIS3mts clinical relevance strictly depended on del(13q) co-occurrence. In particular, bi-allelic DIS3 lesions significantly affected PFS, independently from other predictors of poor clinical outcome, while mono-allelic events mostly impacted OS. As expected, DIS3mts affect MM transcriptome involving cellular processes and signaling pathways associated with RNA metabolism, and the deregulation of a large number of lncRNAs, among which we identified five distinct transcripts as independent predictors of poorer OS and nine of worse PFS, some of which (AC015982.2 and AL445228.3) predicting both. These findings strongly prompt further studies investigating the relevance of these lncRNAs in MM.

DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome / K. Todoerti, D. Ronchetti, V. Favasuli, F. Maura, F. Morabito, N. Bolli, E. Taiana, A. Neri. - In: HAEMATOLOGICA. - ISSN 1592-8721. - 106:10 Suppl. 3(2021 Oct), pp. P19.75-P19.75. [10.3324/haematol.2021.278342]

DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome

K. Todoerti
Primo
;
D. Ronchetti
Secondo
;
V. Favasuli;F. Maura;N. Bolli;E. Taiana
Penultimo
;
A. Neri
Ultimo
2021

Abstract

DIS3 gene mutations (DIS3mts) occur in roughly 10% of multiple myeloma (MM) patients; furthermore, DIS3 expression could be affected by monosomy 13 or del(13q), which occur in approximately 40% of MM cases. Despite several reports on the prevalence of DIS3mts, their contribution to the pathobiology of MM remains largely unknown. We took advantage of the large public CoMMpass dataset to investigate the spectrum of DIS3mts in MM and its impact on the transcriptome and clinical outcome. We found that DIS3mts clinical relevance strictly depended on del(13q) co-occurrence. In particular, bi-allelic DIS3 lesions significantly affected PFS, independently from other predictors of poor clinical outcome, while mono-allelic events mostly impacted OS. As expected, DIS3mts affect MM transcriptome involving cellular processes and signaling pathways associated with RNA metabolism, and the deregulation of a large number of lncRNAs, among which we identified five distinct transcripts as independent predictors of poorer OS and nine of worse PFS, some of which (AC015982.2 and AL445228.3) predicting both. These findings strongly prompt further studies investigating the relevance of these lncRNAs in MM.
Settore MED/15 - Malattie del Sangue
6-mag-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
Todoerti_Haematologica_2021_Epub_compressed.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 2.13 MB
Formato Adobe PDF
2.13 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/844684
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact